End-of-day quote
Trinidad and Tobago S.E.
03:30:00 08/05/2024 am IST
|
5-day change
|
1st Jan Change
|
57
TTD
|
0.00%
|
|
0.00%
|
+5.44%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
10,858
|
9,481
|
9,513
|
9,213
|
10,224
|
8,871
|
Enterprise Value (EV)
1 |
8,748
|
7,062
|
7,356
|
6,056
|
5,715
|
5,006
|
P/E ratio
|
20
x
|
15.6
x
|
14.8
x
|
21.7
x
|
17.2
x
|
44.9
x
|
Yield
|
2.38%
|
3.27%
|
0.54%
|
3.08%
|
3.03%
|
3.5%
|
Capitalization / Revenue
|
1.74
x
|
1.48
x
|
1.44
x
|
1.56
x
|
1.71
x
|
1.36
x
|
EV / Revenue
|
1.4
x
|
1.11
x
|
1.12
x
|
1.02
x
|
0.96
x
|
0.77
x
|
EV / EBITDA
|
8.23
x
|
6.56
x
|
6.98
x
|
6.33
x
|
6.72
x
|
5.9
x
|
EV / FCF
|
10.8
x
|
9.82
x
|
-36.7
x
|
10.7
x
|
5.3
x
|
30.1
x
|
FCF Yield
|
9.24%
|
10.2%
|
-2.72%
|
9.31%
|
18.9%
|
3.32%
|
Price to Book
|
1.54
x
|
1.3
x
|
1.24
x
|
1.15
x
|
1.24
x
|
1.11
x
|
Nbr of stocks (in thousands)
|
1,72,381
|
1,72,386
|
1,72,345
|
1,72,205
|
1,71,856
|
1,72,252
|
Reference price
2 |
62.99
|
55.00
|
55.20
|
53.50
|
59.49
|
51.50
|
Announcement Date
|
30/04/18
|
30/04/19
|
30/04/20
|
03/05/21
|
29/03/22
|
24/04/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
6,244
|
6,385
|
6,593
|
5,919
|
5,970
|
6,525
|
EBITDA
1 |
1,062
|
1,077
|
1,054
|
956.5
|
850.5
|
847.9
|
EBIT
1 |
734.1
|
758.3
|
713.4
|
602.9
|
491.7
|
482.3
|
Operating Margin
|
11.76%
|
11.88%
|
10.82%
|
10.19%
|
8.24%
|
7.39%
|
Earnings before Tax (EBT)
1 |
967.7
|
1,017
|
1,036
|
723.3
|
935.3
|
433.9
|
Net income
1 |
543.6
|
609.4
|
644.8
|
423.2
|
594.8
|
197.7
|
Net margin
|
8.71%
|
9.54%
|
9.78%
|
7.15%
|
9.96%
|
3.03%
|
EPS
2 |
3.150
|
3.536
|
3.740
|
2.460
|
3.450
|
1.147
|
Free Cash Flow
1 |
807.9
|
718.9
|
-200.4
|
563.9
|
1,079
|
166.1
|
FCF margin
|
12.94%
|
11.26%
|
-3.04%
|
9.53%
|
18.07%
|
2.55%
|
FCF Conversion (EBITDA)
|
76.05%
|
66.74%
|
-
|
58.96%
|
126.82%
|
19.59%
|
FCF Conversion (Net income)
|
148.62%
|
117.97%
|
-
|
133.24%
|
181.33%
|
84.02%
|
Dividend per Share
2 |
1.500
|
1.800
|
0.3000
|
1.650
|
1.800
|
1.800
|
Announcement Date
|
30/04/18
|
30/04/19
|
30/04/20
|
03/05/21
|
29/03/22
|
24/04/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
2,111
|
2,419
|
2,157
|
3,157
|
4,508
|
3,865
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
808
|
719
|
-200
|
564
|
1,079
|
166
|
ROE (net income / shareholders' equity)
|
8.39%
|
9.03%
|
9.29%
|
5.74%
|
7.62%
|
2.73%
|
ROA (Net income/ Total Assets)
|
3.25%
|
3.2%
|
2.87%
|
2.39%
|
1.85%
|
1.72%
|
Assets
1 |
16,718
|
19,054
|
22,456
|
17,676
|
32,094
|
11,511
|
Book Value Per Share
2 |
40.90
|
42.40
|
44.60
|
46.30
|
48.00
|
46.60
|
Cash Flow per Share
2 |
11.40
|
9.470
|
10.30
|
16.40
|
14.50
|
12.40
|
Capex
1 |
369
|
355
|
742
|
330
|
364
|
441
|
Capex / Sales
|
5.91%
|
5.56%
|
11.25%
|
5.58%
|
6.09%
|
6.76%
|
Announcement Date
|
30/04/18
|
30/04/19
|
30/04/20
|
03/05/21
|
29/03/22
|
24/04/23
|
|
1st Jan change
|
Capi.
|
---|
| +5.44% | 1.46B | | +5.92% | 104B | | -2.51% | 64.55B | | +51.90% | 41.5B | | +18.29% | 40.01B | | +7.47% | 33.03B | | +10.70% | 20.11B | | +16.99% | 17.52B | | +20.27% | 15.51B | | +10.05% | 15.34B |
Other Commodity Chemicals
|